Hemo Organic Limited reported earnings results for the fourth quarter and full year ended March 31, 2022. For the fourth quarter, the company reported net loss was INR 0.074 million compared to INR 0.159 million a year ago. Basic loss per share from continuing operations was INR 0.02 compared to INR 0.05 a year ago. Diluted loss per share from continuing operations was INR 0.02 compared to INR 0.05 a year ago.
For the full year, sales was INR 0.068 million compared to INR 0.08 million a year ago. Revenue was INR 0.068 million compared to INR 0.08 million a year ago. Net loss was INR 0.624 million compared to INR 0.479 million a year ago. Basic loss per share from continuing operations was INR 0.18 compared to INR 0.14 a year ago. Diluted loss per share from continuing operations was INR 0.18 compared to INR 0.14 a year ago.